120
Views
0
CrossRef citations to date
0
Altmetric
Research Reports

Diagnosed cataracts in patients with cystic fibrosis in a United States administrative database

, , , , &
Pages 527-532 | Received 23 Jul 2016, Accepted 26 Feb 2017, Published online: 10 Apr 2017

References

  • Flume PA, Mogayzel PJ, Jr., Robinson KA, et al. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 2009;180:802–808.
  • Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011;365:1663–1672.
  • Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry: 2009 Annual Data Report. Available at www.cysticfibrosisdata.org/LiteratureRetrieve.aspx?ID=51547. Accessed June 14, 2016.
  • Cystic Fibrosis Foundation Patient Registry: 2014 Annual Data Report. Available at https://www.cff.org/Our-Research/CF-Patient-Registry/. Accessed June 29, 2016.
  • Cystic Fibrosis Foundation. Frequently Asked Questions. Available at http://www.cff.org/AboutCF/faqs. Accessed June 14, 2016.
  • Fama F, Castagna I, Palamara F, et al. Cystic fibrosis and lens opacity. Ophthalmologica 1998;212:178–179.
  • Brennan AL, Geddes DM, Gyi KM, Baker EH. Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 2004;3:209–222.
  • Eigen H, Rosenstein BJ, FitzSimmons S, Schidlow DV. A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group. J Pediatr 1995;126:515–523.
  • Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997;337:8–14.
  • Ernst P, Baltzan M, Deschenes J, Suissa S. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Eur Respir J 2006;27:1168–1174.
  • Hutnik CM, Nichols BD. Cataracts in systemic diseases and syndromes. Curr Opin Ophthalmol 1999;10:22–28.
  • Jacques PF, Moeller SM, Hankinson SE, et al. Weight status, abdominal adiposity, diabetes, and early age-related lens opacities. Am J Clin Nutr 2003;78:400–405.
  • Jobling AI, Augusteyn RC. What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom 2002;85:61–75.
  • Mukesh BN, Le A, Dimitrov PN, Ahmed S, et al. Development of cataract and associated risk factors: the Visual Impairment Project. Arch Ophthalmol 2006;124:79–85.
  • Congdon N, Vingerling JR, Klein BE, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol 2004;122:487–494.
  • Klein BE, Klein R, Lee KE. Incidence of age-related cataract: the Beaver Dam Eye Study. Arch Ophthalmol 1998;116:219–225.
  • Cheung N, Wong TY. Obesity and eye diseases. Surv Ophthalmol 2007;52:180–195.
  • Seliger VI, Bai Y, Volkova N, et al. Prevalence of cataracts in a population of cystic fibrosis patients homozygous for the F508del mutation. J Cyst Fibros 2015;14:S108.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.